Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC

INTRODUCTION: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different assessment methods, have led to increasing controvers...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Pedro, Ramal, Didac, Ripoll, Enric, Moliner, Laura, Corbera, Alex, Hardy-Werbin, Max, Orrillo, Mayra, Taus, Álvaro, Zuccarino, Flavio, Gibert, Joan, Perera-Bel, Júlia, Casadevall, David, Arriola, Edurne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474364/
https://www.ncbi.nlm.nih.gov/pubmed/34589976
http://dx.doi.org/10.1016/j.jtocrr.2020.100115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474364/
https://www.ncbi.nlm.nih.gov/pubmed/34589976
http://dx.doi.org/10.1016/j.jtocrr.2020.100115

Ejemplares similares